Morgan Stanley (MS) Up 5.4% Since Last Earnings Report: Can It Continue?

Morgan Stanley reported strong Q2 2025 results, with EPS of $2.13 and net revenues of $16.79 billion, both significantly exceeding consensus estimates and marking 17% and 12% year-over-year growth respectively. This outperformance was primarily fueled by robust equity and fixed-income trading, coupled with substantial revenue and asset growth in its Wealth Management and Investment Management divisions. While Investment Banking fees remained subdued, the firm's solid capital position and reauthorization of a $20 billion share repurchase program underpin its resilience and positive H2 2025 outlook for M&A and underwriting, contributing to a 5.4% share price increase since the report, outperforming the S&P 500.

Analysis

Morgan Stanley's Q2 2025 results demonstrated significant operational strength, with earnings of $2.13 per share and net revenues of $16.79 billion handily beating consensus estimates and marking year-over-year growth of 17% and 12%, respectively. The performance highlights the success of the firm's diversified model, where robust trading revenues, particularly a 23% surge in equity trading, and impressive growth in the Wealth Management and Investment Management divisions offset cyclical weakness in Investment Banking. The Wealth Management and Investment Management segments delivered substantial pre-tax income growth of 21% and 45% respectively, supported by a 14% rise in total client assets to $6.49 trillion. However, this top-line strength was tempered by a 10% increase in non-interest expenses and a notable surge in the provision for credit losses to $196 million, substantially up from $76 million in the prior-year quarter. The company's capital position remains solid, and a newly authorized $20 billion share repurchase program underscores management's confidence, which hinges on an anticipated recovery in M&A and underwriting activity in the second half of 2025.

Key Decisions for Investors

• The strong performance in Wealth Management and Trading validates the firm's diversified strategy, and the new $20 billion share repurchase authorization provides a significant catalyst for shareholder returns.
• Investors should closely monitor the substantial increase in provisions for credit losses as a potential indicator of emerging credit stress, as well as track whether management's guided second-half recovery in investment banking materializes.
• Given the stock's 5.4% outperformance since the earnings report and its neutral 'Hold' rating with a weak 'D' score for value, it may be prudent to consider that much of the positive news is priced in, warranting caution before initiating new long positions.